Synergistic Effect of Ginsenoside Rh2 Combines with Ionizing Radiation on CT26/<i>luc</i> Colon Carcinoma Cells and Tumor-Bearing Animal Model
Background: The local tumor control rate of colon cancer by radiotherapy is unsatisfactory due to recurrence and radioresistance. Ginsenoside Rh2 (Rh2), a panoxadiol saponin, possesses various antitumor effects. Methods: CT26/<i>luc</i> murine colon carcinoma cells and a CT26/<i>lu...
Main Authors: | Shan-Chih Lee, Chao-Yu Shen, Wei-Hsun Wang, Yen-Po Lee, Keng-Wei Liang, Ying-Hsiang Chou, Yeu-Sheng Tyan, Jeng-Jong Hwang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/16/9/1188 |
Similar Items
-
Anticancer activity of ginsenosides Rh2 on various cancer cells
by: Seun Eui Kim, et al.
Published: (2023-09-01) -
Glycosyltransformation of ginsenoside Rh2 into two novel ginsenosides using recombinant glycosyltransferase from Lactobacillus rhamnosus and its in vitro applications
by: Dan-Dan Wang, et al.
Published: (2021-01-01) -
Biotransformation of Ginsenoside Rf to Rh1 by Recombinant β-Glucosidase
by: Yi-Nan Zheng, et al.
Published: (2009-06-01) -
A stereo-selective growth inhibition profile of ginsenoside Rh2 on human colon cancer cells
by: Yunju Jeong, et al.
Published: (2019-01-01) -
Protective effect of ginsenoside Rh3 against anticancer drug-induced apoptosis in LLC-PK1 kidney cells
by: Hye Lim Lee, et al.
Published: (2017-04-01)